Lambrinoudaki I - Search Results

1

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi ML, Cano A, Collins P, Cooper C, Genazzani AR, Hillard T, Kanis JA, Kaufman JM, Lambrinoudaki I, Laslop A, McCloskey E, Palacios S, Prieto-Alhambra D, Reginster JY, Rizzoli R, Rosano G, Trémollieres F, Harvey NC. Rozenberg S, et al. Among authors: lambrinoudaki i. Osteoporos Int. 2020 Dec;31(12):2271-2286. doi: 10.1007/s00198-020-05497-8. Epub 2020 Jul 8. Osteoporos Int. 2020. PMID: 32642851 Free PMC article. Review.

2

Cardiometabolic health in premature ovarian insufficiency.

Stevenson JC, Collins P, Hamoda H, Lambrinoudaki I, Maas AHEM, Maclaran K, Panay N. Stevenson JC, et al. Among authors: lambrinoudaki i. Climacteric. 2021 Oct;24(5):474-480. doi: 10.1080/13697137.2021.1910232. Epub 2021 Jun 25. Climacteric. 2021. PMID: 34169795 Free article. Review.

3

Efficacy and safety of DT56a compared to hormone therapy in Greek post-menopausal women.

Labos G, Trakakis E, Pliatsika P, Augoulea A, Vaggopoulos V, Basios G, Simeonidis G, Creatsa M, Alexandrou A, Iliodromiti Z, Kassanos D, Lambrinoudaki I. Labos G, et al. Among authors: lambrinoudaki i. J Endocrinol Invest. 2013 Jul-Aug;36(7):521-6. doi: 10.3275/8926. Epub 2013 Apr 8. J Endocrinol Invest. 2013. PMID: 23563111 Clinical Trial.

4

The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Lambrinoudaki I, Karaflou M, Kaparos G, Grigoriou O, Alexandrou A, Panoulis C, Logothetis E, Creatsa M, Christodoulakos G, Kouskouni E. Lambrinoudaki I, et al. J Endocrinol Invest. 2010 Nov;33(10):720-4. doi: 10.1007/BF03346677. Epub 2010 Apr 30. J Endocrinol Invest. 2010. PMID: 20436265 Clinical Trial.

5

Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Papadias C, Sarandakou A, Liakakos T, Alexandrou A, Creatsas G. Christodoulakos G, et al. Among authors: lambrinoudaki i. Eur J Endocrinol. 2004 Aug;151(2):187-92. doi: 10.1530/eje.0.1510187. Eur J Endocrinol. 2004. PMID: 15296473 Clinical Trial.

6

Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.

Panoulis C, Lambrinoudaki I, Vourtsi A, Augoulea A, Kaparos G, Aravantinos L, Christodoulakos G, Creatsas G. Panoulis C, et al. Among authors: lambrinoudaki i. Climacteric. 2009 Jun;12(3):240-7. doi: 10.1080/13697130802684601. Climacteric. 2009. PMID: 19387881 Clinical Trial.

7

Menopausal symptoms are associated with subclinical atherosclerosis in healthy recently postmenopausal women.

Lambrinoudaki I, Augoulea A, Armeni E, Rizos D, Alexandrou A, Creatsa M, Kazani M, Georgiopoulos G, Livada A, Exarchakou A, Stamatelopoulos K. Lambrinoudaki I, et al. Climacteric. 2012 Aug;15(4):350-7. doi: 10.3109/13697137.2011.618564. Epub 2011 Dec 1. Climacteric. 2012. PMID: 22132748

8

Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.

Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G. Christodoulakos G, et al. Among authors: lambrinoudaki i. Maturitas. 2005 Apr 11;50(4):321-30. doi: 10.1016/j.maturitas.2004.08.002. Maturitas. 2005. PMID: 15780533

9

Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women.

Tentolouris N, Christodoulakos G, Lambrinoudaki I, Mandalaki E, Panoulis C, Maridaki C, Creatsas G, Katsilambros N. Tentolouris N, et al. Among authors: lambrinoudaki i. J Endocrinol Invest. 2005 Apr;28(4):305-11. doi: 10.1007/BF03347195. J Endocrinol Invest. 2005. PMID: 15966502 Clinical Trial.

10

Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells?

Sioulas VD, Politi E, Rizos D, Augoulea A, Kyroudi A, Sergentanis TN, Panoulis C, Aravantinos L, Creatsa M, Lambrinoudaki I. Sioulas VD, et al. Among authors: lambrinoudaki i. Climacteric. 2012 Apr;15(2):181-5. doi: 10.3109/13697137.2011.604144. Epub 2011 Nov 8. Climacteric. 2012. PMID: 22066937

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters